Danish Tobacco Stock News

ISS has announced that it previously secured a three-year Integrated Facility Services contract, worth close to DKK 300 million annually, to become the primary facilities partner for a major life sciences and pharmaceutical company across four Swiss locations starting in the second quarter of 2026. By moving from a subcontractor role to direct ownership of a wide range of technical, cleaning, logistics and laboratory services under one integrated FM setup, ISS is deepening its position in a...

RTX (CPSE:RTX) Q1 2026 earnings snapshot RTX (CPSE:RTX) opened its 2026 financial year with Q1 revenue of DKK115.9 million, a basic EPS loss of DKK1, and net income excluding extra items at a loss of DKK8.3 million. This sets a cautious tone around profitability to start the year. Over the prior year, quarterly revenue has moved between DKK104.0 million in Q1 2025 and DKK165.5 million in Q2 2025. Basic EPS ranged from a loss of DKK0.90 in Q1 2025 to a high of DKK0.99 in Q2 2025, highlighting...

Alm. Brand (CPSE:ALMB) has wrapped up FY 2025 with fourth quarter revenue of DKK3.97b and basic EPS of DKK0.20, closing out a year where trailing twelve month revenue came in at DKK14.0b and EPS at DKK0.80. Over recent quarters the company has seen revenue range from DKK3.26b in Q1 2025 to DKK3.97b in Q4, while quarterly EPS moved from DKK0.11 to DKK0.20 across the same period. This has set the backdrop for earnings that lifted net margins to 8.4% from 5.7% a year earlier, a combination of...

It's not a stretch to say that Carlsberg A/S' ( CPH:CARL B ) price-to-earnings (or "P/E") ratio of 16.8x right now...

In January 2026, Tryg A/S reported fourth-quarter 2025 earnings, with net income rising to DKK 1,277 million from DKK 786 million a year earlier, and the company also moved past the ex-dividend date for a DKK 2.05 cash payout on January 23, 2026. Alongside the stronger quarterly profit, recent share grants to senior management highlight how incentives at Tryg are increasingly tied to the company’s performance. Next, we’ll examine how Tryg’s sharp fourth-quarter profit increase shapes its...

Most readers would already be aware that UIE's (CPH:UIE) stock increased significantly by 18% over the past three...

Amid renewed trade and geopolitical uncertainty, the pan-European STOXX Europe 600 Index recently ended 0.98% lower, reflecting a broader decline across major European stock indexes. Despite this downturn, opportunities may exist for investors seeking stocks that could be trading below their estimated value, particularly in sectors where business activity remains positive and confidence is on the rise. Identifying undervalued stocks often involves looking at companies with strong fundamentals...

In January 2026, Genmab reported that worldwide 2025 net trade sales of DARZALEX, as reported by Johnson & Johnson, reached US$14.35 billion, generating ongoing royalty revenue for Genmab, and released positive topline Phase 3 EPCORE DLBCL-1 results showing epcoritamab monotherapy improved progression-free survival in relapsed or refractory DLBCL versus standard regimens. The combination of a very large, royalty-generating DARZALEX franchise and clinically meaningful Phase 3 data for...

Vestas Wind Systems (CPSE:VWS) is back in focus after European countries agreed on plans for 100 GW of shared offshore wind capacity in the North Sea, and Vestas shares rose 5.2% on the news. See our latest analysis for Vestas Wind Systems. The North Sea pact has arrived on top of a strong run in Vestas’ shares, with a 90 day share price return of 46.61% and a 1 year total shareholder return of 103.98% from a starting point that had seen weaker multi year outcomes. Recent gains, including a...

A.P. Møller - Mærsk has resumed part of its Red Sea–Suez Canal sailings with conditional routing, while also appointing Charles van der Steene as Regional Managing Director for the Indian Subcontinent, Middle East & Africa from 1 January 2026 and progressing a share buy-back program of up to DKK 14.40 billion announced in February 2025. Together, these developments highlight Maersk’s mix of operational risk management, regional leadership continuity and capital return decisions at a time of...

Amid renewed trade and geopolitical uncertainty, the European stock market has seen declines, with the pan-European STOXX Europe 600 Index ending 0.98% lower. Despite these challenges, business activity in the eurozone remains positive, offering a glimmer of optimism for investors seeking opportunities in undervalued stocks. In this context, identifying stocks trading below their intrinsic value can be crucial for investors looking to capitalize on potential market inefficiencies and position...

Share buy-back launch puts Aktieselskabet Schouw (CPSE:SCHO) in focus Aktieselskabet Schouw (CPSE:SCHO) has moved into the spotlight after launching a share buy-back programme of up to DKK 240 million through 2026, a capital allocation decision that can influence both valuation and trading interest. See our latest analysis for Aktieselskabet Schouw. That buy-back announcement lands after a steady run in the share price, with a 30-day share price return of 4.67% and a 90-day share price return...

Event driven focus on Demant’s evolving platform Demant (CPSE:DEMANT) is refocusing around a comprehensive audio healthcare platform. The platform is built on custom chipsets, on device AI, and an integrated retail and diagnostics footprint that ties hardware, software, and clinical services together. See our latest analysis for Demant. At a DKK233.2 share price, Demant’s recent 1 month share price return of 8.97% and year to date share price return of 9.28% sit against a 1 year total...

The Board of Directors of Alm. Brand (CPSE:ALMB) has recommended an ordinary dividend of DKK 0.66 per share for the 2025 financial year, corresponding to a total payout of DKK 0.9b. See our latest analysis for Alm. Brand. At a share price of DKK18.16, Alm. Brand has had a mildly weaker recent patch, with a 1 month share price return of a 3.51% decline, even though its 1 year total shareholder return of 25.93% points to momentum that has built over a longer horizon. If this dividend news has...

With its stock down 12% over the past month, it is easy to disregard Zealand Pharma (CPH:ZEAL). However, a closer look...

Coloplast A/S' ( CPH:COLO B ) price-to-earnings (or "P/E") ratio of 33.6x might make it look like a strong sell right...

A.P. Møller - Mærsk (CPSE:MAERSK B) is structurally returning to its Red Sea Suez Canal route, resuming transits through the corridor despite ongoing regional security concerns. The change affects how Maersk routes a portion of its Asia Europe and related services, shifting some traffic back from longer alternative routes. This decision comes as other global carriers continue to use rerouting options around Africa in response to the same security risks. For you as an investor, this move...

The recent installation of the last turbine at Ørsted (CPSE:ORSTED) Greater Changhua 2b and 4 offshore wind farms in Taiwan has sharpened investor focus on how these Asia Pacific projects might influence the stock. See our latest analysis for Ørsted. Ørsted shares have gained momentum recently, with a 30 day share price return of 16.05% and a year to date share price return of 7.62%. This comes even though the 1 year total shareholder return is a 6.86% decline and the 5 year total shareholder...

If you are wondering whether Novozymes is attractively priced or looking stretched at today’s levels, you are in the right place for a clear, valuation focused rundown of the stock. The share price last closed at DKK 412.0, with returns of 2.6% over the past year and 25.2% over three years. Shorter term moves include a 2.4% decline over 7 days, a 1.8% gain over 30 days, and a 3.8% return year to date. Recent news coverage around Novozymes has largely centered on its role in specialty enzymes...

Why Pandora’s 2025 Guidance Has Grabbed Investor Attention Pandora (CPSE:PNDORA) has put fresh numbers on the table, guiding for a Q4 2025 EBIT margin of around 33.5% and full year EBIT of about DKK 7.8b, with a group margin near 24%. This earnings outlook, presented on the Q4 2025 guidance call, gives readers clearer visibility on profitability expectations at a time when the share price has faced pressure over the past year. See our latest analysis for Pandora. The guidance comes after a...

Tryg (CPH:TRYG) has had a rough month with its share price down 1.6%. However, the company's fundamentals look pretty...

RIAS A/S ( CPH:RIAS B ) has announced that on 26th of January, it will be paying a dividend ofDKK26.00, which a...

To the annoyance of some shareholders, Pandora A/S ( CPH:PNDORA ) shares are down a considerable 26% in the last month...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...